Page results
-
This page is for parents, carers and relatives whose child is having radiotherapy treatment to a part of the brain. This page breaks down the side effects your child may experience during and after treatment, and how best to cope with them.
-
This page has been written for parents, carers and family members who are acting as carers and comforters for children and young people having radioactive mIBG and topotecan (MATIN) treatment.
-
This diary is intended for patients undergoing thoracic surgery as a way of involving you in your recovery before your surgery as well as after.
-
This page explains what vaginal dilation therapy is and includes a step-by-step guide to how it should be performed. If you have any questions, please talk to your healthcare team.
-
This page explains how PIFU will work for you once you have finished your treatment for lymphoma.
-
This leaflet explains what strong opioid patches are, and how they are used for pain relief at UCLH.
-
Information for patients undergoing VATS for drainage of air or fluid, pleural biopsies and talc pleurodesis.
-
Information for patients having VATS/Thoracotomy procedure.
-
Information for patients having a robotic-assisted thoracic surgery (RATS).
-
This page explains more about the Prostate One-Day Clinic and what you can expect when you come for your appointment. If you have any questions about your appointment or the information included on this page, please contact one of our prostate clinical nurse specialists (CNSs).
File results
-
FOI/2022/0186 - Gender neutral toilets at the Trust
-
FOI/2022/0187 - Intra-operative cell salvage procedures
-
FOI/2022/0189 - Drug treatments for Revolade, Nplate, Doptelet, and Tavlesse
-
FOI/2022/0190 - Spend on private healthcare providers for staff
-
FOI/2022/0192 - Drug treatment for Melanoma patients
-
FOI/2022/0193 - Drug treatment for breast cancer
-
FOI/2022/0194 - Drug treatment for lung cancer
-
FOI/2022/0199 - Trust postal service and patient communication
-
FOI/2022/0200 - IT budget/ chatbots
-
FOI/2022/0205 - Spending on communication activities